Feinstein Institutes Receives $1.7M NIH Grant to Study Origins of Hereditary Blood Disorder
September 09, 2020
September 09, 2020
MANHASSET, New York, Sept. 9 (TNSGra) -- Feinstein Institutes for Medical Research issued the following news:
To research new treatments for hereditary hemorrhagic telangiectasia (HHT) - a genetic bleeding disorder in which blood vessels do not form properly - the National Institutes of Health (NIH) has awarded Philippe Marambaud, PhD, professor in the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research, a four-year, $1.675 million grant.
HH . . .
To research new treatments for hereditary hemorrhagic telangiectasia (HHT) - a genetic bleeding disorder in which blood vessels do not form properly - the National Institutes of Health (NIH) has awarded Philippe Marambaud, PhD, professor in the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research, a four-year, $1.675 million grant.
HH . . .